Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

vs.MS

- PMLiVE

GSK to hire doctors as product champions

Will use in-house personnel instead of external speakers to present information

Biogen Idec building

NICE turns down Biogen Idec’s oral MS drug

UK HTA body says Tecfidera is not a cost-effective use of NHS resources

- PMLiVE

Infographic: Digitally-native HCPs

Key data on the how doctors' use of digital is changing

Are you talking to digital natives?

In 2014, ‘digitally-native HCPs’ will outnumber ‘digital immigrants’ – yet pharma’s marketing spend and strategy still disproportionally targets an ageing and less impressionable demographic

- PMLiVE

Interview: Laure Thibaud, Sanofi

Sanofi’s head of communications talks about her mission to build a team fit for the modern age

- PMLiVE

Electronic medical records industry to soar

Report says market will hit $17bn by 2017

Biogen Idec building

EC approves Biogen’s oral MS drug Tecfidera

Will compete with Novartis' Gilenya and Sanofi's Aubagio

Harnessing insight from online networks

How can pharma use online doctor networks to best effect in 2014?

- PMLiVE

GPs turning to digital for information

Survey shows UK doctors value medical journals and their websites

- PMLiVE

NICE recommends Sanofi’s oral MS drug

Aubagio backed for NHS use in England and Wales

- PMLiVE

New year, new attitudes in digital

The real digital innovations in 2014 need to come in our attitudes, not our technologies

- PMLiVE

Royalty Pharma buys bigger Tecfidera interest

Agrees $510m deal with Biogen Idec for IP share of multiple sclerosis drug

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links